Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Management of extrapyramidal side effects induced by neuroleptics.

Tune LE, McHugh PR, Coyle JT.

Johns Hopkins Med J. 1981 Mar;148(3):149-53. No abstract available.

PMID:
7206408
2.

Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.

Stenson RL, Donion PT, Meyer JE.

Compr Psychiatry. 1976 Nov-Dec;17(6):763-8. No abstract available.

PMID:
791573
3.

Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?

Neu C, Dimascio A, Demirgian E.

Curr Ther Res Clin Exp. 1972 May;14(5):246-51. No abstract available.

PMID:
4623975
4.

Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.

Swett C Jr, Cole JO, Shapiro S, Slone D.

Arch Gen Psychiatry. 1977 Aug;34(8):942-3.

PMID:
889418
5.

Meige syndrome: relief on high-dose anticholinergic therapy.

Duvoisin RC.

Clin Neuropharmacol. 1983 Mar;6(1):63-6.

PMID:
6850651
6.
7.

The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.

Sovner R, Dimascio A.

Am J Psychiatry. 1977 Nov;134(11):1301-2. No abstract available.

PMID:
910992
8.

Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.

Singh MM, Smith JM.

J Nerv Ment Dis. 1973 Jul;157(1):50-8. No abstract available.

PMID:
4713306
9.

Benztropine psychosis.

Ananth JV, Jain RC.

Can Psychiatr Assoc J. 1973 Oct;18(5):409-14. No abstract available.

PMID:
4746144
10.
11.

Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics.

Tune L, Coyle JT.

Psychopharmacology (Berl). 1981;75(1):9-15.

PMID:
6117922
12.

Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.

Klett CJ, Caffey E Jr.

Arch Gen Psychiatry. 1972 Apr;26(4):374-9. No abstract available.

PMID:
4552131
13.

Drug-induced acute dystonic reactions in children. Alternatives to diphenhydramine therapy.

Dahiya U, Noronha P.

Postgrad Med. 1984 Apr;75(5):286-7, 290. No abstract available.

PMID:
6143309
14.

Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects.

Tune L, Coyle JT.

Arch Gen Psychiatry. 1980 Mar;37(3):293-7.

PMID:
6102457
15.

Acute drug-induced extrapyramidal syndromes.

De Silva KL, Muller PJ, Pearce J.

Practitioner. 1973 Sep;211(263):316-20. No abstract available.

PMID:
4759239
16.

Neuroleptic-induced extrapyramidal side effects.

Lavin MR.

Am J Psychiatry. 1993 Nov;150(11):1752-3. No abstract available.

PMID:
8214193
17.

[Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].

Delaunay J, Guibert S.

Ann Med Psychol (Paris). 1976 Jan;1(1):144-7. French. No abstract available.

PMID:
970819
18.

A controlled trial of amantadine in drug-induced extrapyramidal disorders.

DiMascio A, Bernardo DL, Greenblatt DJ, Marder JE.

Psychopharmacol Bull. 1977 Jul;13(3):31-3. No abstract available.

PMID:
18755
19.

Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?

Nair S, Saeed O, Shahab H, Sedky K, Garver D, Lippmann S.

Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):231-2. No abstract available.

PMID:
11569473
20.

Amantadine in drug-induced extrapyramidal signs: a comparative study.

Ananth J, Sangani H, Noonan JP.

Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):323-6.

PMID:
239908

Supplemental Content

Support Center